OBJECTIVES: The aim of this study was to determine whether cytokine expression (interleukin [IL]-1beta, IL-6, IL-8, IL-10, and tumor necrosis factor [TNF]-alpha), C-reactive protein, and endotoxins on the first day of intensive care unit (ICU) admission are associated with hospital mortality in severe community-acquired pneumonia (CAP). DESIGN: This was a prospective study with bronchoalveolar lavage (BAL) and blood sampling. SETTING: This study was carried out in a 44-bed medical ICU of a 1700-bed university hospital. PATIENTS: Participants included 112 mechanically ventilated patients with severe CAP. INTERVENTIONS: Serum and BAL fluid IL-1beta, IL-6, IL-8, IL-10, TNF-alpha, C-reactive protein, and endotoxins on the first day of ICU admission were obtained. MEASUREMENTS AND MAIN RESULTS: The concentrations of TNF-alpha in BALF and IL-6, IL-8, IL-10, and TNF-alpha in serum were higher in nonsurvivors than in survivor patients with CAP. Of these 112 patients with severe CAP (39%), 44 developed acute respiratory distress syndrome (ARDS); these patients seemed to have higher serum IL-6, IL-8, and IL-10 levels than did the non-ARDS group. Furthermore, in the ARDS population, we found that the endotoxin levels in the BAL fluid were higher in the survival than in the nonsurvival group and BAL fluid concentrations of IL-6, IL-8, and IL-1beta and sera levels of IL-6 and IL-10 were lower in the survival than in the nonsurvival group, and they were associated with a high negative predictive value. CONCLUSIONS: Serum and BAL fluid levels of the studied cytokines on admission may provide valuable prognostic information for patients with severe CAP. Copyright 2010 Elsevier Inc. All rights reserved.
OBJECTIVES: The aim of this study was to determine whether cytokine expression (interleukin [IL]-1beta, IL-6, IL-8, IL-10, and tumor necrosis factor [TNF]-alpha), C-reactive protein, and endotoxins on the first day of intensive care unit (ICU) admission are associated with hospital mortality in severe community-acquired pneumonia (CAP). DESIGN: This was a prospective study with bronchoalveolar lavage (BAL) and blood sampling. SETTING: This study was carried out in a 44-bed medical ICU of a 1700-bed university hospital. PATIENTS: Participants included 112 mechanically ventilated patients with severe CAP. INTERVENTIONS: Serum and BAL fluid IL-1beta, IL-6, IL-8, IL-10, TNF-alpha, C-reactive protein, and endotoxins on the first day of ICU admission were obtained. MEASUREMENTS AND MAIN RESULTS: The concentrations of TNF-alpha in BALF and IL-6, IL-8, IL-10, and TNF-alpha in serum were higher in nonsurvivors than in survivor patients with CAP. Of these 112 patients with severe CAP (39%), 44 developed acute respiratory distress syndrome (ARDS); these patients seemed to have higher serum IL-6, IL-8, and IL-10 levels than did the non-ARDS group. Furthermore, in the ARDS population, we found that the endotoxin levels in the BAL fluid were higher in the survival than in the nonsurvival group and BAL fluid concentrations of IL-6, IL-8, and IL-1beta and sera levels of IL-6 and IL-10 were lower in the survival than in the nonsurvival group, and they were associated with a high negative predictive value. CONCLUSIONS: Serum and BAL fluid levels of the studied cytokines on admission may provide valuable prognostic information for patients with severe CAP. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Helena M Linge; Ji Young Lee; Kanta Ochani; Kiyokazu Koga; Nina Kohn; Kaie Ojamaa; Saul R Powell; Edmund J Miller Journal: Exp Lung Res Date: 2015-04-06 Impact factor: 2.459
Authors: Heather Lynn; Xiaoguang Sun; Nancy Casanova; Manuel Gonzales-Garay; Christian Bime; Joe G N Garcia Journal: Antioxid Redox Signal Date: 2019-06-18 Impact factor: 8.401
Authors: Djillali Annane; Stephen M Pastores; Wiebke Arlt; Robert A Balk; Albertus Beishuizen; Josef Briegel; Joseph Carcillo; Mirjam Christ-Crain; Mark S Cooper; Paul E Marik; Gianfranco Umberto Meduri; Keith M Olsen; Bram Rochwerg; Sophia C Rodgers; James A Russell; Greet Van den Berghe Journal: Intensive Care Med Date: 2017-09-21 Impact factor: 17.440
Authors: Andreas Schwingshackl; Bin Teng; Manik Ghosh; Keng Gat Lim; Gabor Tigyi; Damodaran Narayanan; Jonathan H Jaggar; Christopher M Waters Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-12-28 Impact factor: 5.464
Authors: Chris Winkelman; Kimberly D Johnson; Rana Hejal; Nahida H Gordon; James Rowbottom; Janis Daly; Karen Peereboom; Alan D Levine Journal: Intensive Crit Care Nurs Date: 2012-03-28 Impact factor: 3.072
Authors: Keely L Buesing; John C Densmore; Sushma Kaul; Kirkwood A Pritchard; Jason A Jarzembowski; David M Gourlay; Keith T Oldham Journal: J Surg Res Date: 2010-06-09 Impact factor: 2.192
Authors: Michael C Seeds; Bonnie L Grier; Bruce N Suckling; Anca M Safta; David L Long; B Moseley Waite; Peter E Morris; R Duncan Hite Journal: Am J Med Sci Date: 2012-06 Impact factor: 2.378
Authors: Andreas Schwingshackl; Dai Kimura; Cynthia R Rovnaghi; Jordy S Saravia; Stephania A Cormier; Bin Teng; Alina N West; Umberto G Meduri; Kanwaljeet J S Anand Journal: Cytokine Date: 2015-11-03 Impact factor: 3.861